Advanced Enzyme Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.
Advanced Enzyme produces over 400 proprietary products developed from 60 enzymes. Advanced Enzyme operates in two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food).
Advanced Enzyme has 13 patents registered in its name and applications for registration of 4 patents are pending.
Advanced Enzyme is among top 15 companies in enzyme sales in the world and 2nd largest in India. Company has over 20 years of fermentation experience in the production of enzymes. Companies offer these products to its more than 700 global customers across 50 countries around the world.
Advanced Enzyme's R&D team consists of over 55 scientists, microbiologists, engineers, food technologists and biotechnologists. Company has four R&D facilities, of which two are located at Thane, and one each at Sinner and Chino, California.
Competitive strengths of the company:
1. Integrated Company with presence across the Enzyme Value Chain
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows
The promoters of the company are:
1. Mr. Chandrakant Laxminarayan Rathi
2. Mr. Vasant Laxminarayan Rathi
|Particulars||For the year/period ended (in Rs. Million)|
|Profit After Tax (PAT)||784.35||501.02||200.86||492.19||333.36|
Objects of the Issue:
The Offer consists of a Fresh Issue by the company and an Offer for Sale by the Selling Shareholders.
1. Offer for Sale
Company will not receive any proceeds from the Offer for Sale.
2. The Fresh Issue
The object of the fresh issue is to invest in Advanced Enzymes USA, the wholly owned subsidiary for repayment / pre-payment of certain loans availed by Advanced Enzymes USA; and general corporate purposes.
»» Issue Open: Jul 20, 2016 – Jul 22, 2016
»» Issue Type: Book Built Issue IPO
»» Issue Size:
› Fresh Issue of [.] Equity Shares of Rs 10 aggregating up to Rs 50.00 Cr
› Offer for Sale of 4,034,470 Equity Shares of Rs 10 aggregating up to Rs [.] Cr
»» Face Value: Rs 10 Per Equity Share
»» Issue Price: Rs. 880 – Rs. 896 Per Equity Share
»» Market Lot: 16 Shares
»» Minimum Order Quantity: 16 Shares
»» Listing At: BSE, NSE